UDP-glucuronosyltransferase (UGT), a phase II drug-metabolizing enzyme, is expressed in the brain and can catalyze glucuronidation of endogenous and exogenous substrates in the brain. Thus, changes in UGT1A expression could affect homeostasis and drug efficacy. Phenobarbital (PB), a typical inducer of drug-metabolizing enzymes, has been reported to induce oxidative stress and epigenetic changes, which could alter UGT expression in the brain. Here, we aimed to clarify the effects of PB on Ugt1a6 and Ugt1a7 gene expression in rat brains. Sprague-Dawley rats were treated intraperitoneally with PB (80 mg/kg), once daily for 7 days. Ugt1a6 and Ugt1a7 mRNA expression levels were increased in the striatum and thalamus (Ugt1a6: 3.0-and 2.9-fold, respectively; Ugt1a7: 2.6-and 2.6-fold, respectively). Acetaminophen glucuronidation was also increased in the medulla oblongata and thalamus by 1.8-and 1.2-fold, respectively. The induction rates within different brain regions were correlated with Ugt1a6 and Ugt1a7 mRNA expression, and the degree of induction also correlated with that of Nrf2 mRNA.
Introduction
Many drug-metabolizing enzymes (DMEs) are expressed primarily in the liver and play important roles in the metabolism of various exogenous and endogenous compounds.
Because some DMEs are also found in extrahepatic tissues, including the brain, local brain metabolism could affect the efficacy of central-acting drugs and endogenous compounds, independent of liver metabolism (Dutheil et al., 2008; Miksys and Tyndale, 2013) .
UDP-glucuronosyltransferase (UGT) catalyzes a major phase II reaction and has been reported to be expressed in brain tissues, neurons, and astrocytes (King et al., 1999; Suleman et al., 1998; Shelby et al., 2003) . Therefore, UGT1As in the brain would be involved in mediating the pharmacological effects of several central-acting drugs as UGT substrates, such as acetaminophen (APAP) (Court et al., 2001) , amitriptyline (Green et al., 1998) , and valproic acid (Ethell et al., 1998) . UGT1As also catalyze the glucuronidation of neurotransmitters and neurosteroids, such as serotonin (Krishnaswamy et al., 2003) 5 target gene transcription. Ugt1a6 mRNA has been reported to be increased by PB in the rat liver (Kato et al., 2005) . Moreover, previous studies have revealed that PB induces oxidative stress in the rat liver and brain (Dostalek et al., 2008; Reeta et al., 2011) .
Oxidative stress can activate the Nrf2 signaling pathway, and Ugt1a6 and Ugt1a7 mRNA levels are increased by oxidative stress in rat astrocytes (Reeta et al., 2011) . Since Ugt1a6 is expressed in the rat brain, neurons, and astrocytes (Shelby et al., 2003; Sulman et al., 1998) , PB is thought to have the potential to change the expression of Ugt1a6 and Ugt1a7 isoforms in the rat brain.
PB can also alter DNA methylation and histone modifications (Watson and Goodman, 2002; Lempiäinen et al., 2011) . Such epigenetic changes are involved in gene regulation prior to transcriptional activation. In a previous study, PB-mediated changes in DNA methylation and histone modification were shown to be associated with the upregulation of cytochrome P450 (Cyp) 2b10 (a CAR target gene) in mice (Lempiäinen et al., 2011) .
Moreover, CAR activation has been shown to be related to epigenetic changes at the promoter region of CAR target genes (Chen et al., 2012) . Thus, Ugt1a6 and Ugt1a7 can be induced by PB and affect drug metabolism and homeostasis in the brain.
The purpose of this study was to ascertain whether changes of UGT1A6 and UGT1A7 occurred in rat brain due to PB. If such changes occurred, we sought to clarify their mediating mechanisms.
per unit volume was calculated. The standard series and samples were run under the same conditions. PCR was performed using Thermal Cycler Dice instrument from TaKaRa Bio (Shiga, Japan) with SYBR Premix Ex Taq II (TaKaRa Bio). The primers used for quantification of UGT mRNA are described in Table 2 and were commercially synthesized by Greiner Bio-one. The PCR amplification conditions were as follows:
initial denaturation at 95°C for 30 s; 40 cycles of denaturation at 95°C for 5 s; and annealing and extension at 60°C for 30 s. Taqman Gene expression assays was used to determine the expression of Cyp2b1 mRNA (Rn01457880_m1; Applied Biosystems, Carlsbad, CA). PCR amplification was performed with the same conditions described above. All data were normalized to the expression level of β -actin. Data are shown as the mean values from five rats in each group.
Preparation of microsomes
Pooled rat brain microsomes were prepared from 10 rats according to the methods described previously (Sakakibara et al., 2015) and stored at -80°C until analysis. Protein concentrations were determined using Bio-Rad Protein Assay kit (Bio-Rad, Hercules, CA).
APAP glucuronidation
APAP glucuronidation was determined using the method described by Sakakibara et al.
(2014) with slight modifications. In a preliminary study, we confirmed the linearity of the protein concentrations, substrate concentration, and incubation times. The concentrations of APAP and brain microsomes were 1 mM and 0.5 mg/mL, respectively. The reaction mixture was incubated at 37°C for 60 min. Data are presented as the mean of three
8 independent determinations using pooled brain microsomes from 10 rats.
Immunoblot analysis
T he pooled cytoplasmic and nuclear extracts of the striatum and thalamus from rat brains and livers were prepared using NE-PER Nuclear and Cytoplasmic Extraction
Reagents (Thermo Fisher Scientific, Waltham, MA) according to the manufacturer's instructions. The cytoplasmic and nuclear extracts were collected and stored at -80°C until SDS polyacrylamide gel electrophoresis and immunoblotting. Immunodetection was performed with a polyclonal rabbit anti-CAR antibody (ab35850; abcam, Cambridge, MA) at a 1:1000 dilution. Immunodetection for glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and Lamin B1 was carried out using anti-GAPDH antibody (ab8245; abcam; 1:500 dilution) and anti-Lamin B1 antibody (ab16048; abcam; 1:5000 dilution), respectively. The bands were scanned using ImageQuant LAS-4010 instrument and quantitated with ImageQuant TL (GE Healthcare Life Science, Uppsala, Sweden).
Thiobarbituric acid reactive substances (TBARS) measurement
For determination of TBARS levels, brain tissues from five rats were pooled and homogenized in 10 volumes (w/v) of 1.15% KCl. TBARS was measured according to the method described by Ohkawa et al. (1979) . TBARS were calculated as nmol of TBARS per mg of protein.
Glutathione assay
For determination of the glutathione levels, brain tissues from five rats were pooled and homogenized in 5% sulfosalicylic acid in an ice-water bath. Homogenates consisting of 100 mg tissue in 1 mL (10%) were centrifuged at 8,000 g for 10 min at 4°C to remove
proteins. Supernatants were assayed for glutathione using GSSG/GSH Quantification Kit (Dojindo, Kumamoto, Japan) according to the manufacturer's instructions.
Effects of PB and NAC treatment on Ugt1a6, Ugt1a7 and Cyp2b1 expression in rat hepatocytes Hepatocytes were isolated from 5-week-old male Sprague-Dawley rats (n = 5) using a two-step collagenase perfusion method. Drug treatments were initiated 24 h after plating.
Hepatocytes were treated with 2 mM PB and/or 10 mM NAC for 72 h and were collected for RNA preparation.
DNA methylation assay
Genomic DNA from pooled rat brains (n = 5) was extracted with phenol/chloroform followed by ethanol precipitation (Brilliant et al., 1991) and was assayed for methylated DNA using Methylated DNA Quantification kit (abcam) according to the manufacturer's instructions.
Histone modification assay
Histone extracts from pooled rat brains (n = 5) were prepared using EpiSeeker Histone Extraction Kit (abcam). The histone extracts were assayed for histone modification using Histone H3 (tri-methyl K4), Histone H3 (tri-methyl K9), and Histone H3 (acetyl K9)
Quantification Kits (abcam) according to the manufacturer's instructions.
Quantification of PB concentrations
The concentrations of PB in plasma and brain tissues were measured by high-performance liquid chromatography with tandem mass spectrometry. 
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Following treatment with PB, Ugt1a6 and Ugt1a7 mRNA levels were increased in the piriform cortex, hippocampus, medulla oblongata, olfactory bulb, striatum, and thalamus; the degree of induction differed among the nine regions examined in this study (Fig. 1 ).
Ugt1a6 and Ugt1a7 mRNA levels were particularly increased in the striatum and thalamus (Ugt1a6: 3.0-and 2.9-fold, respectively; Ugt1a7: 2.6-and 2.6-fold, respectively). The degrees of induction of Ugt1a6 and Ugt1a7 were correlated (r = 0.92, p < 0.001).
Effects of PB on APAP glucuronidation in rat brains
APAP glucuronidation, which is catalyzed mainly by Ugt1a6 and Ugt1a7, was determined in the medulla oblongata, striatum, and thalamus, where relatively high 
Effects of PB on the expression levels of nuclear receptors in rat brains
The constitutive expression levels of CAR and Nrf2 mRNAs were detected in all nine regions of the brain, with different degrees of expression (Figs. 2 and 4A). Following treatment with PB, CAR mRNA was not changed in any of the brain regions, with the exception of the medulla oblongata (Fig. 2) . Although the expression of the nuclear CAR
12 protein was increased by 1.5-fold in the liver, it was not increased in the striatum or thalamus, where Ugt1a6 and Ugt1a7 mRNA levels were increased by PB (Fig. 3) .
Following PB treatment, Nrf2 mRNA was increased in the hippocampus, medulla oblongata, olfactory bulb, striatum, and thalamus by 1.3-, 1.3-, 1.6-, 2.4-, and 2.0-fold, respectively (Fig. 4A) . The degree of induction of Nrf2 mRNA by PB was correlated with that of Ugt1a6 and Ugt1a7 mRNAs (Ugt1a6: r = 0.97, p < 0.001; Ugt1a7: r = 0.90, p < 0.001) (Fig. 4B ).
Effects of PB on oxidative stress markers in rat brains
The level of TBARS (lipid peroxidation) and total glutathione (nonenzymatic antioxidant defenses) were significantly increased in the medulla oblongata, olfactory bulb, striatum, and thalamus after PB treatment (Figs. 5A and 5B). HO-1 mRNA (regulated by Nrf2) was increased in all nine regions (Fig. 6) , and the fold changes of HO-1 mRNA correlated with those of Ugt1a6 and Ugt1a7 mRNA (Ugt1a6:
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Effects of PB on DNA methylation and histone modifications in rat brains
Following treatment with PB, DNA methylation was unchanged in five brain regions (Fig. 8A) . Histone H3 lysine 4 (H3K4) trimethylation was increased by 2.7-and 2.9-fold in the striatum and thalamus, respectively (Fig. 8B) , whereas histone H3 lysine 9 (H3K9) trimethylation was decreased by 0.34-fold in the thalamus (Fig. 8C ). H3K9 acetylation was unchanged in the five regions (Fig. 8D) .
Concentrations of PB in rat brains
The PB concentrations in the brain and plasma were quantified at 1 and 24 h after the last treatment. There were no significant differences in PB concentrations in any brain region at 1 and 24 h (Table 3) .
Discussion
In the present study, we found that the expression levels of Ugt1a6 and Ugt1a7 mRNAs in the rat brain were increased by PB. The degree of induction differed among the nine examined brain regions, and those of Ugt1a6 and Ugt1a7 mRNAs were correlated.
Therefore, the increases in Ugt1a6 and Ugt1a7 mRNA levels can be attributed to similar mechanisms.
PB is a typical inducer promoting the nuclear translocation of CAR, which is normally 14 transcriptional activation (Honkakoski et al., 1998) . In the present study, the expression of the nuclear CAR protein was increased in the liver following PB treatment, whereas the accumulation of CAR protein in the nucleus was not observed in the striatum and thalamus, where the expression levels of Ugt1a6 and Ugt1a7 mRNAs were increased (Fig.   3 ). In some brain regions, such as the cortex, hippocampus, striatum, and thalamus, PB and 2,4,6-tryphenuldioxane did not affect CYP2B expression; in contrast, these agents 15 consistent with a previous study in rats (Reeta et al., 2011) . The brain may be more susceptible to oxidative stress because it contains high levels of unsaturated fatty acids, which are the main targets of free radicals and cellular lipid peroxides. Measurement of TBARS is meaningful as an oxidative stress marker in the brain. Moreover, the level of total glutathione was also increased in some brain regions (Fig. 5B) . Such increases in glutathione levels could result from the increase in of Ugt1a6 and Ugt1a7 mRNAs by PB in rat hepatocytes. Our data showed that NAC exposure inhibited the induction of Ugt1a6, Ugt1a7, and HO-1 mRNAs but not Cyp2b1 mRNA (Fig. 7) . These results indicated that Ugt1a6 and Ugt1a7 mRNAs were increased by oxidative stress derived from PB.
H3K4 trimethylation correlates with activation of gene expression, whereas H3K9
trimethylation is associated with gene silencing (Kimura, 2013). Moreover, H3K4
trimethylation is increased by oxidative stress (Niu et al, 2015) . In the present study, H3K4 trimethylation was increased in the striatum and thalamus, and H3K9 trimethylation was decreased in the thalamus. Moreover, the degree of induction of
Ugt1a6 and Ugt1a7 mRNAs by PB in the striatum and thalamus was higher than those in other regions. These results suggested that the regional differences in the degree of the induction in Ugt1a6 and Ugt1a7 may be associated with differences in epigenetic changes induced by PB in the rat brain.
From the above results, we hypothesized that oxidative stress generated by PB and histone modifications may be involved in the transcriptional activation of Ugt1a6 and Ugt1a7; however, the degrees of induction were not associated with the concentrations of PB in each of the nine brain regions (Table 3) . A capacities and responses to oxidative stress among the nine brain regions may be varied, which would be expected to cause differences in the transcriptional activation of Ugt1a6 and Ugt1a7 among the nine brain regions.
In the present study, PB increased not only Ugt1a6 and Ugt1a7 mRNAs but also APAP 
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Ugt1a6 and Ugt1a7 mRNA expression levels in the striatum. A previous report showed that human UGT1A mRNA and protein levels did not always correlate with each other (Izukawa et al., 2009; Ohtsuki et al., 2012; Oda et al., 2012) , suggesting that the level of induction of Ugt mRNA does not correlate with the induction of glucuronidation activities. To determine changes in Ugt1a6 and Ugt1a7 enzyme activities in detail may require more specific Ugt1a6 and Ugt1a7 substrates. Similar to previous reports, our data suggested that an unexplained epigenetic mechanism may be involved in the post-transcriptional regulation of Ugt1a6 and Ugt1a7 in the rat brain. Each column represents the mean ± SD of three independent determinations. *p < 0.05, **p < 0.01 compared with the controlf Fig. 6 . Effects of PB on HO-1 mRNA in rat brains.
The expression of HO-1 mRNA was calculated as the value relative to that of the control in the cerebellum. The mRNA expression level was normalized to the expression of β -actin mRNA. Each column represents the mean ± SD of three independent determinations. *p < 0.05, **p < 0.01, ***p < 0.001 compared with the control. Percentages were calculated as the values relative to that of the control in the cerebellum.
Each column represents the mean ± SD of three independent determinations. *p < 0.05 compared with the control. 
